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Abstract
Background: Nance-Horan Syndrome (NHS) (OMIM: 302350) is a rare X-linked developmental disorder characterized by
bilateral congenital cataracts, with occasional dental anomalies, characteristic dysmorphic features, brachymetacarpia and
mental retardation. Carrier females exhibit similar manifestations that are less severe than in affected males.
Methods: Here, we report a four-generation Chinese family with multiple affected individuals presenting Nance-Horan
Syndrome. Whole-exome sequencing combined with RT-PCR and Sanger sequencing was used to search for a genetic
cause underlying the disease phenotype.
Results: Whole-exome sequencing identified in all affected individuals of the family a novel donor splicing site mutation
(NM_198270: c.1045 + 2T > A) in intron 4 of the gene NHS, which maps to chromosome Xp22.13. The identified mutation
results in an RNA processing defect causing a 416-nucleotide addition to exon 4 of the mRNA transcript, likely producing
a truncated NHS protein.
Conclusions: The donor splicing site mutation NM_198270: c.1045 + 2T > A of the NHS gene is the causative mutation in
this Nance-Horan Syndrome family. This research broadens the spectrum of NHS gene mutations, contributing to our
understanding of the molecular genetics of NHS.
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Background
Nance-Horan Syndrome (NHS) (OMIM: 302350) was first
described in detail by two independent studies in 1974 as a
rare X-linked developmental disorder characterized by
congenital cataracts, with occasional dental anomalies,
brachymetacarpia and mental retardation [1–4]. It is inher-
ited as an X-linked recessive trait, whereby heterozygous
females manifest a similar but milder disease phenotype
than affected males [5].
The NHS (Nance-Horan syndrome) gene has been
mapped to chromosome Xp22.13 [6]. The gene is composed
of 10 coding exons in an approximately 650-kb [7] region,
encoding at least four isoforms as a result of alternative
splicing. The two major isoforms, NHS-A and NHS-1A, are
transcribed from exon 1 and comprise 1630 amino acids and
1651 amino acids, respectively. NHS-B, a 1335-amino acid
protein, is transcribed from exon 1b; NHS-C, a 1453-amino
acid protein, is transcribed from exon 1a [8–10].
To date, at least 33 mutations [11–15], including 6 from
the Chinese population, have been reported in the NHS
gene, many of which are nonsense mutations or InDels,
with few copy number variations and missense and splice
site mutations. In this study, we report the identification of
a novel splice site mutation in the NHS gene in a Chinese
family with NHS. This report broadens the spectrum of
NHS gene mutations implicated in NHS pathogenesis.
Methods
Study subjects and clinical characterization
A four-generation family with multiple affected individuals
was recruited from Guangdong Province (Fig. 1a). Pedigree
analysis suggests X-linked inheritance. Approval of this
study was obtained from the Institutional Review Board
(IRB) of the State Key Laboratory of Medical Genetics
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(SKLMG). All of the procedures were performed in accord-
ance with the relevant policies in China and adhered to the
tenets of the Declaration of Helsinki. After obtaining
written informed consent, the affected members of this
family were given a clinical examination at the Second
Xiangya Hospital, Central South University, P.R.C. Medical
and ophthalmic histories were recorded. Genomic DNA
was extracted from venous blood of 6 affected and 4
normal family members; amniotic fluid was used for a fetus
of uncertain status. Lymphoblastoid cell lines were estab-
lished through Epstein-Barr virus (EBV) transformation of
B-lymphocytes from an affected subject (II: 5), a carrier (II:
2) and a control.
Whole-exome sequencing
We performed whole-exome sequencing of an affected
male (II: 3) from this family. All procedures including read
mapping and variant analysis were as described previously
[16]. Variants predicted to alter the protein sequence were
filtered as follows: 1) extraction of exonic non-synonymous
single-nucleotide variants (SNVs), splice site SNVs and
short insertions and deletions (InDel); 2) exclusion of high-
Fig. 1 a The pedigree of the family with NHS gene mutations: clear and filled symbols represent unaffected and affected individuals, respectively. A
dotted circle indicates an obligate X-linked carrier, whereas a “#” symbol indicates a fetus. Deceased individuals are indicated with a slash. Individuals
with “*” were recruited and analyzed. “m” and “+” refer to mutant and normal alleles, respectively. b Photograph of the right eye of an affected male
(III: 1), indicating a nuclear cataract. c Photograph of the teeth of an affected male (III: 1) presenting diastema (d). Radiographs of the right and left
hands of an affected male (II: 5), indicating brachymetacarpia. e Sequence chromatogram of the Chinese family with the novel NHS gene mutation;
the upper panel represents the nucleotide sequence of an unaffected male, the middle panel that of an affected male, and the lower panel that of
a carrier female; an arrow indicates the site of mutation
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frequency (MAF > 0.01) polymorphisms in the ESP6500
and 1000 Genomes databases; 3) extraction of variants in
cataract-causing genes. Whole-exome sequencing was
followed by Sanger sequencing to verify the variants
detected.
Sanger sequencing and RT-PCR
To validate the variants identified by the filtering proced-
ure, Sanger sequencing using an ABI PRISM 3730 DNA
Sequencer (Applied Biosystems, Foster City, CA) was per-
formed by amplifying targeted genomic regions in candi-
date genes. Primers flanking the candidate variant in the
NHS (NM_198270) and PAX6 (NM_000280) genes were
designed using Primer3 software (http://frodo.wi.mit.edu/).
The NHS gene forward and reverse primers were 5′-
TTTGTTTGCAGTCCCATCCC-3′ and 5′-GCCCGCGG
AAAACATGTAAA-3′, respectively. The PAX6 gene for-
ward and reverse primers were 5′-TTCCACGGTG-
TATCTGCAAA-3′ and 5′-CAATGTGGTCGATGTGTC
CC-3′, respectively. Co-segregation analysis between candi-
date genes and the disease phenotype was carried out using
Sanger-sequenced DNA samples for all available family
members. For reverse transcription-PCR (RT-PCR), RNA
was extracted from lymphoblastoid cell lines established for
two patients (II; 2, II; 5) and one control using the Trizol
reagent (Thermo Fisher Scientific, 168 Third Avenue,
Waltham, MA USA 02451), as described by the manufac-
turer. First-strand cDNA was synthesized using RevertAid™
First Strand cDNA Synthesis Kit (Thermo Fisher Scientific,
168 Third Avenue, Waltham, MA USA 02451) following
the manufacturer’s instructions. RT-PCR for NHS cDNA
was performed using primers for exon 4 (forward primer
5′-ACAGATGTCATGTTAGGGCAG-3′) and exon 6
(reverse primer 5′-TATCCTCGGTTTGGCACTCA-3′).
Amplicons were visualized on 1.2% agarose gels stained
with ethidium bromide. Sanger sequencing was performed
to validate variations in mRNA sequences. Sequence ana-
lysis was performed by comparing sequence data with the
reference genome using DNASTAR software.
Results
Clinical findings
Two affected male subjects (II: 5, III: 1) available at the
time of clinical examination presented with bilateral con-
genital nuclear cataracts, one of whom received cataract
surgery at the age of 30 years. Additional ocular features
recorded in the affected subjects include microcornea,
high myopia, nystagmus and strabismus. Brachymetacar-
pia was noted in both affected male subjects, and charac-
teristic facial features of a long narrow face and prominent
nose were exhibited by one male subject (II: 5). Mild men-
tal retardation and diastema were observed in the other
male subject (III: 1); the teeth of the other affected male
(II: 5) could not be evaluated because of tooth loss due to
aging. Heterozygous obligate carrier females (II: 2, III: 7)
received cataract surgery a long time before the family
was recruited for the present study. Nonocular features
observed included brachymetacarpia in both carriers (II: 2,
III: 7) and diastema in one (III: 7). A detailed description
of the clinical features of the affected and carrier family
members are summarized in Table 1.
Exome sequencing identified an NHS splice site variation
Exome sequencing generated 4.93 Gb of sequence data,
allowing the targeted region of the genome to be exam-
ined more than 50 times. A summary of the whole-
exome sequencing results is provided in Additional file
1. Exome sequencing initially identified 24,403 coding
SNVs and InDels. After the filtering procedure, 11,992
variants were retained, including exonic nonsynonymous
and splice site mutations and InDels. Among these, 2226
variants were found to be low-frequency (MAF < 0.01)
polymorphisms in the ESP6500 and 1000 Genomes
databases (See Additional file 2). For this study, we
focused only on variants detected in reported cataract-
causing genes. These included c.G451A and c.1045 +
2T > A in the PAX6 and NHS genes, respectively (See
Additional file 3). These two variants were further
validated by Sanger sequencing of 10 family members
(including male member II: 3 who underwent exome se-
quencing) and one fetus. Only NHS gene mutation
c.1045 + 2T > A was detected in all 6 patients but not in
4 unaffected family members and 200 control subjects.
The fetus was identified as a heterozygote (m/+). The
identified mutation causes a T-to-A transversion in the
splice donor site of intron 4 of the NHS gene. The
pathogenic sequence variant reported here was found in
the heterozygous state (m/+) in obligate carrier females














+ + + +
Microcornea + + + +
Nystagmus + + + +
Microphthalmia - - - -
High myopia + + + +
Strabismus + + + +
Non-ocular
features
Brachymetacarpia + + + +
Prominent nose + - - -
Long and narrow
face
+ - - -
Diastema NA + NA +
Mental retardation - + - -
NA not available
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and in a hemizygous state (m) in affected males, co-
segregating with the disease phenotype as an X-linked
recessive trait.
RT-PCR and sequencing
To assess whether the T >A substitution in the splice
donor site of intron 4 of the NHS gene affects precursor
mRNA splicing, we performed an RT-PCR experiment
using RNA extracted from lymphoblast cell lines estab-
lished for two patients (II: 2, II: 5) and one control. Agarose
gel electrophoresis of the resulting PCR products showed
amplicons of two different lengths. A shorter amplicon of
approximately 421 bp detected in the control subject
corresponded with the expected band size. An additional
aberrant amplicon of 837 bp was detected in the carrier
female (II: 2), whereas the affected male (II: 5) presented
only an aberrant amplicon (837 bp) (Fig. 2a). Sequencing of
the RT-PCR product revealed an insertion of 416 nucleo-
tides (c.1045G_1046Gins416bp) in exon 4 due to abnormal
splicing occurring at a cryptic splice site in the patients
compared to the control (Fig. 2b). This splice site mutation
results in a premature stop codon 6 amino acids down-
stream (Fig. 2c), leading to protein truncation.
Discussion
The study presented here describes the clinical and mo-
lecular genetic analysis of a Chinese family exhibiting
Nance-Horan Syndrome (NHS). Mutations in the NHS
gene have been reported from various populations
throughout the world, including Turkish, Indian, Tunisian,
Australian, Taiwanese, European and Chinese populations.
Clinical evaluation of the available affected male subjects
revealed typical NHS ocular and nonocular features that
are more severe than in obligate carriers, in concordance
Fig. 2 a RT-PCR analysis of the splice site mutation in the NHS gene. Samples were from a normal female, a carrier female and an affected male.
The RT-PCR product separated by 1.2% agarose gel electrophoresis is a band of the expected size (421 bp) in the normal female and an aberrant
band of 837 bp in the affected male (II: 5); bands of both sizes (421 bp and 837 bp) are observed in the carrier female (II: 2); “M” denotes the 100
bp ladder, and “–” represents the negative control. b Chromatogram of RT-PCR product sequencing. The upper panel represents the sequence
for normal splicing in the control subject, the middle panel represents the sequence for normal and aberrant splicing in a carrier female (II: 2), the
lower panel represents the sequence for aberrant splicing with insertion of 416 nucleotides in exon 4 in an affected male (II: 5). c Sequence of
nucleotides and corresponding amino acids in the mutated NHS protein aligned with reference sequence; the premature stop codon is indicated
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with previous reports [8, 11, 17]. Both affected male sub-
jects experienced profound vision loss, and one (II: 5)
underwent cataract surgery. Mild mental retardation was
exhibited by an affected male (III: 1) in this family. Mental
retardation in NHS is highly variable and has been re-
ported in 20–30% of affected subjects, which suggests it is
a major component of the NHS syndrome [5].
NHS carrier females manifest mild and variable phe-
notypes. In one study, Y-sutural posterior lens opacities
associated with microcornea and dental anomalies was
observed in 100% of carrier females [18, 19], though car-
riers presenting clear to total lens opacities with small
cornea, strabismus and nystagmus have also reported
[11]. In our carrier females (II: 2; III: 7), cataract was no
longer observed due to cataract surgery prior to the
study. Although both carriers were of normal intellect,
with normal facial features, microcornea, nystagmus,
high myopia and strabismus were found.
Whole-exome sequencing followed by Sanger sequen-
cing of variants identified a novel splice site mutation
(c.1045 + 2T > A) in the NHS gene, mapping to the short
arm of chromosome Xp22.13.
Splice site mutations represent a significant proportion of
gene alterations leading to Mendelian disorders [20]. Such
mutations influencing precursor mRNA splicing either re-
sult in complete skipping of one or more exons, retention
of introns, creation of a pseudo-exon or activation of a
cryptic splice site with in an exon or an intron [21]. Activa-
tion of cryptic splice site is the second most frequent conse-
quence of splicing defect after exon skipping [22]. The
identified sequence variant (c.1045 + 2T >A) in the NHS
gene, located just after exon 4 at the 5′ consensus donor
site, disrupts the natural splicing of exons 4-5.
The presence of aberrant splicing in the NHS gene
caused by the NM_198270; c.1045 + 2T > A mutation
was experimentally assessed by RT-PCR. Gel analysis
showed and confirmed the presence of amplicons of two
different lengths (421 bp, 837 bp) in a carrier female
compared to a shorter amplicon (421 bp) in a control
and a longer amplicon (837 bp) in an affected male.
Sanger sequencing of cDNA confirmed the addition of
416 nucleotides to the mutated sequence.
The female fetus was at the 22nd week of gestation at the
time of sample collection for DNA extraction. Sequencing
of the NHS gene revealed the splice site mutation in a
heterozygous state (m/+). Sonographic scan of the fetus
(data not shown) and follow-up ophthalmological examin-
ation after birth confirmed the presence of congenital cata-
ract, in concordance with the molecular genetic analyses.
The NHS protein has multiple isoforms, and cell type-
dependent differential expression is observed. The two
major isoforms, NHS-A and NHS -1A, which are impli-
cated in the pathogenesis of NHS, contain a functional
WAVE homology domain at the N-terminus. This domain
interacts with members of the Abelson-interactor (Abi)
family and contributes to actin remodeling regulation and
maintenance of cell morphology [9]. NHS-A, the neuronal
and epithelial-specific isoform, is mainly expressed in the
human eye lens, and the encoded protein associates with
the peripheral cell membrane in the lens epithelium [23].
The identified splice site substitution in intron 4 induces a
putative premature stop codon 7 codons downstream
(p.G349-IVLVFSX), which is likely to result in a truncated
NHS protein. Truncating mutations may lead to nonsense
mediated decay (NMD), which results in complete loss of
mutated proteins. However, it has been reported that
some mRNAs harboring premature termination codons
located in some specific regions can escape the NMD
pathway, leading to an abnormal protein product [24].
Previously described RT-PCR analysis for a truncating
mutation in exon 1(c.115C > T; Q39X) of the NHS gene in
an Indian NHS family found no evidence of NMD
pathway involvement [17]. In the present study, RT-PCR
analysis depicting the presence of an aberrant mRNA
transcript in the affected and carrier subjects also sug-
gested escape from the NMD pathway. As a possible con-
sequence, a truncated NHS protein composed of 355
amino acids with a damaging effect would be produced in
the cells of these individuals, causing the disease pheno-
type. However, additional work is required to understand
the exact pathogenic mechanism underlying NHS.
Conclusions
In summary, whole-exome sequencing coupled with
Sanger sequencing revealed a novel splice site mutation
(NM_198270: c.1045 + 2T > A) in the 5’ consensus donor
site of intron 4 in the NHS gene in a Chinese family.
This mutation led to aberrantly spliced mRNA, which is
likely to result in a truncated NHS protein. This work
extends the genetic spectrum of NHS and contributes to
knowledge of the molecular genetics involved. In addition,
the present work signifies the importance of whole-exome
analysis in gene discovery studies and the genetic-
diagnosis of disease in the clinical examination as well.
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